Supplement Is Recalled Due to Ingredient Mix-Up

by Staff Blogger | February 25th, 2014

February 25, 2014

The U.S Food and Drug Administration (FDA) recently announced the voluntary recall of a medication used to treat children suffering genetic disorders. The recall was initiated due to the medications containing the wrong ingredients.

An FDA Press Release stated drug manufacturer Medisca’s L-citrulline supplement can be used to treat children suffering from certain genetic disorders and has been shown to be effective in treating erectile dysfunction during trials. However, testing by FDA investigators showed several lots of the drug did not contain the active ingredient at all. Instead, the medications contained N-Acetyl-leucine, a compound that is used to treat patients afflicted with vertigo.

Experts say that such a mistake could not only cause a patient serious harm if the affected medications are taken, it may also result in death.

That is why the FDA is asking any doctors or medical facilities in possession of the affected medications to quarantine them immediately. Anyone harmed by the affected medications should report the incident to the FDA immediately.

The Drug Injury Attorneys with Ferrer, Poirot & Wansbrough would also encourage anyone who has been injured by the affected supplement to discuss their legal options with an attorney immediately in order to help protect any potential rights to compensation.